NICE news from FierceBiotech
News
Pharma turns cold shoulder to UK
Roche and Merck Serono recently sized up their chances to pass muster with the UK's cost-effectiveness regulators and decided to give NICE a pass. Analysts say that the clinical- and Read more...
Get more NICE coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets